KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to 23.09%.

  • Bausch Health Companies' EBITDA Margin rose 104200.0% to 23.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.92%, marking a year-over-year increase of 46700.0%. This contributed to the annual value of 16.06% for FY2024, which is 50700.0% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' EBITDA Margin is 23.09%, which was up 104200.0% from 17.55% recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' EBITDA Margin registered a high of 27.19% during Q3 2021, and its lowest value of 12.86% during Q2 2021.
  • For the 5-year period, Bausch Health Companies' EBITDA Margin averaged around 10.16%, with its median value being 12.67% (2024).
  • In the last 5 years, Bausch Health Companies' EBITDA Margin tumbled by -232300bps in 2021 and then soared by 257900bps in 2023.
  • Quarter analysis of 5 years shows Bausch Health Companies' EBITDA Margin stood at 5.07% in 2021, then plummeted by -312bps to 10.76% in 2022, then skyrocketed by 240bps to 15.03% in 2023, then soared by 45bps to 21.81% in 2024, then grew by 6bps to 23.09% in 2025.
  • Its EBITDA Margin stands at 23.09% for Q3 2025, versus 17.55% for Q2 2025 and 12.22% for Q1 2025.